AbCellera Biologics Inc. ABCL Payments To Acquire (Proceeds from) Long Term Investments And Other Assets
Payments To Acquire (Proceeds from) Long Term Investments And Other Assets at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept abcl:PaymentsToAcquireProceedsFromLongTermInvestmentsAndOtherAssets.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s payments to acquire (proceeds from) long term investments and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s payments to acquire (proceeds from) long term investments and other assets?
- AbCellera Biologics Inc. (ABCL) reported payments to acquire (proceeds from) long term investments and other assets of $105K in Q1 2026.
- How has AbCellera Biologics Inc.'s payments to acquire (proceeds from) long term investments and other assets changed year-over-year?
- AbCellera Biologics Inc.'s payments to acquire (proceeds from) long term investments and other assets decreased by 98.6% year-over-year, from $7.48M to $105K.
- What does payments to acquire (proceeds from) long term investments and other assets mean?
- This metric tracks the net cash outflows or inflows related to the acquisition or disposal of long-term investments and other non-current assets. It provides insight into how the company allocates capital toward long-term strategic holdings beyond standard marketable securities.